SinoMab BioScience Limited (HKG:3681)
Hong Kong · Delayed Price · Currency is HKD 1.090
-0.020 (-1.80%)
Aug 27, 2026, 3:41 PM HKT
SinoMab BioScience Market Cap
SinoMab BioScience has a market cap or net worth of 1.54 billion as of August 27, 2026. Its market cap has decreased by -57.98% in one year.
Market Cap
1.54B
Enterprise Value
1.50B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.09
ChartMarket Cap Chart
Since November 12, 2019, SinoMab BioScience's market cap has decreased from 6.04B to 1.54B, a decrease of -74.51%. That is a compound annual growth rate of -18.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 1.54B | -17.16% |
| Dec 31, 2025 | 1.86B | 56.14% |
| Dec 31, 2024 | 1.19B | -31.56% |
| Dec 29, 2023 | 1.74B | -7.18% |
| Dec 30, 2022 | 1.87B | -34.91% |
| Dec 31, 2021 | 2.88B | -37.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PegBio | 2.30B |
| AIM Vaccine | 1.98B |
| HighTide Therapeutics | 1.86B |
| Guangzhou Innogen Pharmaceutical Group | 1.84B |
| Mabpharm | 1.77B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.60B |
| Zhaoke Ophthalmology | 1.37B |
| Beijing Biostar Pharmaceuticals | 1.28B |